Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ANALYST INTERVIEW: BRAND DRUG MARKETERS & PRODUCT DEVELOPMENT COMPANIES - ANGELA LARSON - SUSQUEHANNA FINANCIAL GROUP.


(ZFE803) BRAND DRUG MARKETERS & PRODUCT DEVELOPMENT COMPANIES ANGELA LARSON SUSQUEHANNA FINANCIAL GROUP. Reviews the performance of the industry, and examines recent changes that have impacted companies in that sector. Topics discussed include competition, mergers and acquisitions, and the development of customer demand; and a number of companies are identified that are considered well positioned to succeed in the current market. Sector: Pharmaceuticals. Published date 11/12/07. Tickers featured: ACL See access control list.

1. ACL - Access Control List.
2. ACL - Association for Computational Linguistics.
3. ACL - A Coroutine Language.

A Pascal-based implementation of coroutines.

["Coroutines", C.D.
, AGN, BTRX, DRRX, FRX, KG, OMPI OMPI Organisation Mondiale de la Propriété Intellectuelle
OMPI Organización Mundial de la Propiedad Intelectual (Spanish)
OMPI Organizzazione Mondiale per la Proprietà Intellettuale
, SCRX, SEPR SEPR Senior Enlisted Performance Report , SHPGY. Complete text approximately 3000 words. Document # ZFE803.

ANALYST INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: information@twst.com.
COPYRIGHT 2007 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Wall Street Transcript Digest
Date:Nov 12, 2007
Words:108
Previous Article:ANALYST INTERVIEW: OUTLOOK FOR SPECIALTY PHARMACEUTICALS - DAVID LICKRISH - BROADPOINT CAPITAL, INC.
Next Article:ANALYST INTERVIEW: PAIN MANAGEMENT, NEUROPATHY & DERMATOLOGY - DAVID H. WINDLEY - JEFFERIES & COMPANY, INC.
Topics:

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles